We are live on
!
Find out more
Temasek Holdings Portfolio holdings
AUM
$30.5B
1-Year Est. Return
13.98%
This Fund
S&P 500
This Quarter
Est. Return
+20.67%
1 Year Est. Return
+13.98%
3 Year Est. Return
+73.05%
5 Year Est. Return
+59.18%
10 Year Est. Return
+409.11%
AUM
$14.4B
AUM Growth
-$81.5M
(-0.56%)
Cap. Flow
-$2.2B
Cap. Flow
% of AUM
-15.25%
Top 10 Holdings %
Top 10 Hldgs %
72.69%
Holding
61
New
3
Increased
1
Reduced
6
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MNTV
Momentive Global Inc. Common Stock
MNTV
|
+$2.36M |
| 2 |
Microsoft
MSFT
|
+$2.13M |
| 3 |
AMRS
Amyris Inc.
AMRS
|
+$1.74M |
| 4 |
AYX
Alteryx Inc
AYX
|
+$185K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$696M |
| 2 |
Lumen
LUMN
|
+$360M |
| 3 |
Alibaba
BABA
|
+$218M |
| 4 |
Trip.com Group
TCOM
|
+$196M |
| 5 |
Boeing
BA
|
+$170M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 36.29% |
| 2 | Financials | 15.79% |
| 3 | Communication Services | 12.54% |
| 4 | Healthcare | 9.66% |
| 5 | Technology | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Alibaba
BABA
$271B
| $4.76B | 32.94% |
26,075,175
-1,294,000
| -5% | -$218M |
|
|
2
Lumen
LUMN
$6.75B
| $1.17B | 8.07% |
97,259,407
-25,941,800
| -21% | -$360M |
|
3
Dell
DELL
$281B
| $1.07B | 7.39% |
35,872,727
| – | – |
|
4
Visa
V
$673B
| $672M | 4.65% |
4,300,992
| – | – |
|
5
PayPal
PYPL
$49.7B
| $653M | 4.52% |
6,286,524
| – | – |
|
|
INFO
6
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $616M | 4.27% |
11,335,769
-2,079,973
| -16% | -$109M |
|
|
FTSI
7
DELISTED
FTS International, Inc. Common Stock
FTSI
| $416M | 2.88% |
2,080,857
| – | – |
|
8
Thermo Fisher Scientific
TMO
$210B
| $411M | 2.85% |
1,503,087
| – | – |
|
9
Virtu Financial
VIRT
$5.17B
| $401M | 2.78% |
16,880,503
| – | – |
|
10
Mastercard
MA
$471B
| $339M | 2.35% |
1,440,714
| – | – |
|
|
ONC
11
BeOne Medicines Ltd
ONC
$34.3B
| $300M | 2.07% |
2,270,100
| – | – |
|
12
DuPont de Nemours
DD
$18.6B
| $300M | 2.07% |
2,219,267
| – | – |
|
|
WP
13
DELISTED
Worldpay, Inc.
WP
| $275M | 1.91% |
2,426,186
| – | – |
|
|
RDS.B
14
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $232M | 1.61% |
3,635,028
| – | – |
|
|
UNVR
15
DELISTED
Univar Solutions Inc.
UNVR
| $226M | 1.57% |
10,218,695
-3,859,317
| -27% | -$83.2M |
|
16
ZTO Express
ZTO
$18.3B
| $223M | 1.54% |
12,176,750
| – | – |
|
17
NIO
NIO
$11.7B
| $211M | 1.46% |
41,446,985
| – | – |
|
18
BioMarin Pharmaceuticals
BMRN
$11.4B
| $211M | 1.46% |
2,372,712
| – | – |
|
19
PPG Industries
PPG
$25.4B
| $195M | 1.35% |
1,727,645
| – | – |
|
|
PTLA
20
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $180M | 1.24% |
5,174,168
| – | – |
|
|
GRA
21
DELISTED
W.R. Grace & Co.
GRA
| $171M | 1.18% |
2,187,501
| – | – |
|
22
Guardant Health
GH
$20B
| $124M | 0.86% |
1,613,007
| – | – |
|
23
Global Payments
GPN
$21.5B
| $120M | 0.83% |
876,176
| – | – |
|
24
HDFC Bank
HDB
$121B
| $117M | 0.81% |
4,045,060
| – | – |
|
25
Denali Therapeutics
DNLI
$3.75B
| $102M | 0.71% |
4,410,457
| – | – |
|
Similar funds
Temasek Holdings's Q1 2019 Portfolio in Review
As of Q1 2019, Temasek Holdings held 61 positions worth $14.4B, down 0.56% from $14.5B the previous quarter. Its ten largest holdings account for 73% of the portfolio.
Temasek Holdings withdrew a net $2.2B in Q1 2019, closing 11 positions and reducing 6 holdings. Its most notable exit was Gilead Sciences, an estimated $696M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 36% of assets, up from 31% a quarter earlier, followed by Financials and Communication Services.
Against the trend, Temasek Holdings opened a new position in Momentive Global Inc. Common Stock worth $3.05M.
- Temasek Holdings's largest Q1 2019 buy was Momentive Global Inc. Common Stock: 167,620 shares worth $3.05M.
- Temasek Holdings added most to Alteryx Inc in Q1 2019, an estimated $185K increase.
- Temasek Holdings's biggest Q1 2019 reduction was Lumen, cutting an estimated $360M.
- Temasek Holdings fully exited Gilead Sciences in Q1 2019, selling an estimated $696M.
- Temasek Holdings's ten largest holdings make up 73% of its $14.4B portfolio in Q1 2019.
- Temasek Holdings opened 3 new positions and closed 11 in Q1 2019.
- Temasek Holdings's portfolio value fell 0.56% quarter-over-quarter to $14.4B.
Based on Temasek Holdings's 13F filing for Q1 2019, filed 15 May 2019.